Tue, Dec 19, 2023
Stocks of diagnostic test providers such as Dr Lal Pathlabs and Thyrocare were in demand on Tuesday after the government issued guidelines in connection with a new variant of COVID-19 amid an uptick in cases in some parts of the country.
More >
Wed, May 18, 2022
Diagnostic companies Dr Lal Path Labs and Metropolis Healthcare shares were reeling under the pressure on Wednesday and declined even when the markets were trading in the green.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
